Price $161.13 |
Market Cap
8.75B
|
Sector Health Care |
Div. Growth
33.30%
|
|
P/E
13.5
|
P/B
1.48
|
P/S
0.64
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
20.3
|
Op. Cash Flow
1.17M
|
FCF
6.3
|
|
Op. Margin
7.80%
|
Net Margin
4.90%
|
ROE
11.60%
|
ROI
7.40%
|
|
ROA
5.10%
|
EPS Growth
-2.30%
|
Current Ratio
1.3
|
Debt/Equity
79.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.64 | - | - | 28.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.47 | - | - | 4.1M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $109.67 | - | - | 8.13B | Strong Buy |
| Journey Medical Corp (DERM) | $3.54 | - | - | 43.3M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.14 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
